00:37 , Jan 24, 2017 |  BC Extra  |  Financial News

Atlas Genetics raises $35M in series D

Molecular diagnostics company Atlas Genetics Ltd. (Trowbridge, U.K.) raised $35 million in a series D round. New investor Wondfo Biotech participated alongside existing investors Novartis Venture Funds, Consort Medical plc (LSE:CSRT), the Johnson & Johnson...
02:46 , Jan 30, 2015 |  BC Extra  |  Financial News

Atlas Genetics raises $20M in series C round

Diagnostics company Atlas Genetics Ltd. (Trowbridge, U.K.) raised $20 million in a series C round from new investor RMI Partners, a subsidiary of Rusnano, and existing investors Novartis Venture Funds; Consort Medical plc; Johnson &...
07:00 , Oct 23, 2014 |  BC Innovations  |  Cover Story

Diagnosing resistance

It might be a day late and a dollar short, but the U.S. government is finally getting around to addressing what many experts think is the big unserved need in antibiotic resistance-new diagnostics. Faster, more...